SynthesisBMC psychiatry2026
Neuropsychiatric disorders in children of mothers with polycystic ovary syndrome: a systematic review and meta-analysis.
Synthesis in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundPolycystic ovary syndrome (PCOS) is a common endocrine disorder among women of reproductive age, yet its association with neuropsychiatric disorders (NPDs) in offspring remains inconsistent and requires updated synthesis.
methodsWe systematically searched PubMed, Embase, Web of Science, and Cochrane Library up to March 2025. A total of 21 observational studies involving 6.8 million mothers and 7.4 million offspring were included. Quality assessment was performed using the Newcastle-Ottawa Scale. Random-effects meta-analyses were conducted to estimate pooled odds ratios (ORs) with 95% confidence intervals (CIs).
resultsMaternal PCOS was significantly associated with increased risks of autism spectrum disorder (OR = 1.44, 95% CI: 1.36–1.53), attention-deficit/hyperactivity disorder (OR = 1.42, 95% CI: 1.35–1.49), chronic tic disorders (OR = 1.45, 95% CI: 1.24–1.68), anxiety (OR = 1.34, 95% CI: 1.27–1.42), other behavioral/emotional disorders (OR = 1.35, 95% CI: 1.30–1.39), and neurological malformations (OR = 1.47, 95% CI: 1.12–1.94). Subgroup analyses by offspring sex and diagnostic criteria showed consistent effects, though sex differences were not significant. Sensitivity analyses confirmed result stability.
conclusionThis study provides evidence of an association between maternal PCOS and elevated odds of NPDs in children, highlighting the potential importance of prenatal metabolic health and developmental surveillance in this population. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.